Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2B | Q13224 | 12/20 | 0.41 |
| ▸ | GRIN1 | Q05586 | 3/20 | 0.41 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | PMM2 | O15305 | 1/20 | 0.33 |
| ▸ | MPI | P34949 | 1/20 | 0.33 |
| ▸ | PHOSPHO1 | Q8TCT1 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | NOS2 | P35228 | 1/20 | 0.32 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.32 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26047031 | 0.87 | ALOX5 (0.43) | GRIN2BGRIN1ALOX5PMM2MPI | |
| SCHEMBL26047254 | 0.87 | ALOX5 (0.43) | GRIN2BGRIN1ALOX5PMM2MPI | |
| SCHEMBL26047441 | 0.84 | PARP14 (0.32) | PARP14ALOX5PMM2MPIPHOSPHO1 | |
| SCHEMBL17253993 | 0.83 | GRIN2B (0.43) | GRIN2BGRIN1PMM2MPIPHOSPHO1 | |
| SCHEMBL26045257 | 0.81 | GRIN2B (0.44) | GRIN2BGRIN1NOS2 | |
| SCHEMBL20821663 | 0.80 | ATM (0.46) | PARP14ALOX5 | |
| SCHEMBL26056711 | 0.77 | ALOX5 (0.38) | GRIN2BALOX5 | |
| SCHEMBL19169193 | 0.76 | PARP14 (0.40) | PARP14ALOX5 | |
| SCHEMBL24303221 | 0.76 | ALOX5 (0.39) | PARP14ALOX5 | |
| SCHEMBL17775585 | 0.76 | GRIN2B (0.46) | GRIN2BGRIN1PMM2MPIPHOSPHO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230276690-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) | 2023-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230276690-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | L1CAM, TELO2, LIMS1 | GRIN2B 2225/4885GRIN1 1630/4885PARP14 1426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.